Cargando…

External validation of the Gleason grade group system in Argentinian patients that underwent surgery for prostate cancer

INTRODUCTION: The aim of this article was to evaluate the effectiveness of the Gleason grade groups (GGG) system on a group of Argentinian patients with prostate cancer (PC) who underwent radical prostatectomy (RP). MATERIAL AND METHODS: We retrospectively studied 262 patients who underwent RP betwe...

Descripción completa

Detalles Bibliográficos
Autores principales: Bengió, Rubén G., Arribillaga, Leandro, Bengió, Verónica, Epelde, Javier, Cordero, Esteban, Oulton, Guillermo, Carrara, Santiago, Arismendi, Esteban
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Polish Urological Association 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407779/
https://www.ncbi.nlm.nih.gov/pubmed/32782833
http://dx.doi.org/10.5173/ceju.2020.0039
_version_ 1783567683014361088
author Bengió, Rubén G.
Arribillaga, Leandro
Bengió, Verónica
Epelde, Javier
Cordero, Esteban
Oulton, Guillermo
Carrara, Santiago
Arismendi, Esteban
author_facet Bengió, Rubén G.
Arribillaga, Leandro
Bengió, Verónica
Epelde, Javier
Cordero, Esteban
Oulton, Guillermo
Carrara, Santiago
Arismendi, Esteban
author_sort Bengió, Rubén G.
collection PubMed
description INTRODUCTION: The aim of this article was to evaluate the effectiveness of the Gleason grade groups (GGG) system on a group of Argentinian patients with prostate cancer (PC) who underwent radical prostatectomy (RP). MATERIAL AND METHODS: We retrospectively studied 262 patients who underwent RP between 1996 and 2014. To determine the performance and validity of the GGG system, a Kaplan-Meier analysis and multivariate analysis with Cox proportional method were performed to evaluate biochemical recurrence, distance metastases and specific cancer mortality. The area under the curve (AUC) was calculated to compare new groups of degrees of the GGG system with the classical scheme of stratification into 3 groups. RESULTS: The median follow-up was 84 months. As the groups ascend, there is less confined organ disease (p <0.001) and greater extraprostatic extension (p <0.001), greater invasion of seminal vesicles (p <0.001) and greater lymph node involvement (p <0.001). The biochemical recurrence-free survival at 5 years was 68%, 55%, 22%, 9%, 0% of the 1–5 groups, respectively. Ten-years cancer-specific survival was 96%, 95%, 78%, 64%, 25% for group 1–5, respectively. In the multivariate analysis, the GGG system is presented as the only independent predictor of biochemical recurrence and specific cancer mortality. The AUC indicates that the GGG system has a higher prognostic discrimination compared to the classic 3-group system (6, 7, ≥8). CONCLUSIONS: The International Society of Urological Pathology (ISUP) GGG system is an independent predictor of biochemical recurrence and mortality from prostate cancer in patients treated with RP. The classification into 5 groups shows greater discrimination in the prognosis than the traditional Gleason classification.
format Online
Article
Text
id pubmed-7407779
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Polish Urological Association
record_format MEDLINE/PubMed
spelling pubmed-74077792020-08-10 External validation of the Gleason grade group system in Argentinian patients that underwent surgery for prostate cancer Bengió, Rubén G. Arribillaga, Leandro Bengió, Verónica Epelde, Javier Cordero, Esteban Oulton, Guillermo Carrara, Santiago Arismendi, Esteban Cent European J Urol Original Paper INTRODUCTION: The aim of this article was to evaluate the effectiveness of the Gleason grade groups (GGG) system on a group of Argentinian patients with prostate cancer (PC) who underwent radical prostatectomy (RP). MATERIAL AND METHODS: We retrospectively studied 262 patients who underwent RP between 1996 and 2014. To determine the performance and validity of the GGG system, a Kaplan-Meier analysis and multivariate analysis with Cox proportional method were performed to evaluate biochemical recurrence, distance metastases and specific cancer mortality. The area under the curve (AUC) was calculated to compare new groups of degrees of the GGG system with the classical scheme of stratification into 3 groups. RESULTS: The median follow-up was 84 months. As the groups ascend, there is less confined organ disease (p <0.001) and greater extraprostatic extension (p <0.001), greater invasion of seminal vesicles (p <0.001) and greater lymph node involvement (p <0.001). The biochemical recurrence-free survival at 5 years was 68%, 55%, 22%, 9%, 0% of the 1–5 groups, respectively. Ten-years cancer-specific survival was 96%, 95%, 78%, 64%, 25% for group 1–5, respectively. In the multivariate analysis, the GGG system is presented as the only independent predictor of biochemical recurrence and specific cancer mortality. The AUC indicates that the GGG system has a higher prognostic discrimination compared to the classic 3-group system (6, 7, ≥8). CONCLUSIONS: The International Society of Urological Pathology (ISUP) GGG system is an independent predictor of biochemical recurrence and mortality from prostate cancer in patients treated with RP. The classification into 5 groups shows greater discrimination in the prognosis than the traditional Gleason classification. Polish Urological Association 2020-05-09 2020 /pmc/articles/PMC7407779/ /pubmed/32782833 http://dx.doi.org/10.5173/ceju.2020.0039 Text en Copyright by Polish Urological Association http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Original Paper
Bengió, Rubén G.
Arribillaga, Leandro
Bengió, Verónica
Epelde, Javier
Cordero, Esteban
Oulton, Guillermo
Carrara, Santiago
Arismendi, Esteban
External validation of the Gleason grade group system in Argentinian patients that underwent surgery for prostate cancer
title External validation of the Gleason grade group system in Argentinian patients that underwent surgery for prostate cancer
title_full External validation of the Gleason grade group system in Argentinian patients that underwent surgery for prostate cancer
title_fullStr External validation of the Gleason grade group system in Argentinian patients that underwent surgery for prostate cancer
title_full_unstemmed External validation of the Gleason grade group system in Argentinian patients that underwent surgery for prostate cancer
title_short External validation of the Gleason grade group system in Argentinian patients that underwent surgery for prostate cancer
title_sort external validation of the gleason grade group system in argentinian patients that underwent surgery for prostate cancer
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407779/
https://www.ncbi.nlm.nih.gov/pubmed/32782833
http://dx.doi.org/10.5173/ceju.2020.0039
work_keys_str_mv AT bengiorubeng externalvalidationofthegleasongradegroupsysteminargentinianpatientsthatunderwentsurgeryforprostatecancer
AT arribillagaleandro externalvalidationofthegleasongradegroupsysteminargentinianpatientsthatunderwentsurgeryforprostatecancer
AT bengioveronica externalvalidationofthegleasongradegroupsysteminargentinianpatientsthatunderwentsurgeryforprostatecancer
AT epeldejavier externalvalidationofthegleasongradegroupsysteminargentinianpatientsthatunderwentsurgeryforprostatecancer
AT corderoesteban externalvalidationofthegleasongradegroupsysteminargentinianpatientsthatunderwentsurgeryforprostatecancer
AT oultonguillermo externalvalidationofthegleasongradegroupsysteminargentinianpatientsthatunderwentsurgeryforprostatecancer
AT carrarasantiago externalvalidationofthegleasongradegroupsysteminargentinianpatientsthatunderwentsurgeryforprostatecancer
AT arismendiesteban externalvalidationofthegleasongradegroupsysteminargentinianpatientsthatunderwentsurgeryforprostatecancer